Literature DB >> 12066449

Olanzapine-induced mania in bipolar disorders.

Chantal Henry, Jacques Demotes-Mainard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12066449      PMCID： PMC161651     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  6 in total

1.  Mania induced by risperidone: dose related?

Authors:  H Y Lane; Y C Lin; W H Chang
Journal:  J Clin Psychiatry       Date:  1998-02       Impact factor: 4.384

2.  5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.

Authors:  J Ichikawa; H Ishii; S Bonaccorso; W L Fowler; I A O'Laughlin; H Y Meltzer
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

3.  Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.

Authors:  M Tohen; T G Jacobs; S L Grundy; S L McElroy; M C Banov; P G Janicak; T Sanger; R Risser; F Zhang; V Toma; J Francis; G D Tollefson; A Breier
Journal:  Arch Gen Psychiatry       Date:  2000-09

Review 4.  Olanzapine: a review of its use in the treatment of bipolar I disorder.

Authors:  N Bhana; C M Perry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 5.  Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases.

Authors:  J M Aubry; A E Simon; G Bertschy
Journal:  J Clin Psychiatry       Date:  2000-09       Impact factor: 4.384

6.  Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist.

Authors:  M Pilla; S Perachon; F Sautel; F Garrido; A Mann; C G Wermuth; J C Schwartz; B J Everitt; P Sokoloff
Journal:  Nature       Date:  1999-07-22       Impact factor: 49.962
  6 in total
  4 in total

Review 1.  Olanzapine: a review of its use in the management of bipolar I disorder.

Authors:  Paul L McCormack; Lynda R Wiseman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Atypical antipsychotics for the treatment of bipolar disorder: more shadows than lights.

Authors:  Salvatore Gentile
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 3.  Avoiding drug-induced switching in patients with bipolar depression.

Authors:  Chantal Henry; Jacques Demotes-Mainard
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  Bipolar disorder in megalencephalic leukoencephalopathy with subcortical cysts: a case report.

Authors:  Masanori Ishikawa; Yoshie Omachi; Noriko Sato; Eiji Nakagawa
Journal:  BMC Psychiatry       Date:  2020-07-03       Impact factor: 3.630
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.